Amended IN Assembly March 23, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Assembly Bill No. 1619Introduced by Assembly Member DixonFebruary 17, 2023 An act to add Section 4074.1 to the Business and Professions Code, relating to pharmacy. LEGISLATIVE COUNSEL'S DIGESTAB 1619, as amended, Dixon. Pharmacists: drug disclosures: cannabis or cannabidiol interactions. The Pharmacy Law provides for the licensure and regulation of pharmacists by the California State Board of Pharmacy. Existing law requires a pharmacist to inform a patient orally or in writing of the harmful effects of a drug dispensed by prescription if a prescription drug poses a substantial risk to the person consuming the drug when taken in combination with alcohol or if the drug may impair a persons ability to drive a motor vehicle, and the board has determined that the drug is a drug or drug type for which this warning shall be given. A violation of the Pharmacy Law is a crime.This bill would require a pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products to display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information. The bill would require a pharmacy to develop a cannabis labeling guideline on which medications require a label pursuant to the bill. Because a violation of this requirement would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YES Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 4074.1 is added to the Business and Professions Code, to read:4074.1. (a) A pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products shall display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information.(b) A pharmacy shall develop a cannabis labeling guideline on which medications require a label pursuant to subdivision (a).SEC. 2. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
Amended IN Assembly March 23, 2023 CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION Assembly Bill No. 1619Introduced by Assembly Member DixonFebruary 17, 2023 An act to add Section 4074.1 to the Business and Professions Code, relating to pharmacy. LEGISLATIVE COUNSEL'S DIGESTAB 1619, as amended, Dixon. Pharmacists: drug disclosures: cannabis or cannabidiol interactions. The Pharmacy Law provides for the licensure and regulation of pharmacists by the California State Board of Pharmacy. Existing law requires a pharmacist to inform a patient orally or in writing of the harmful effects of a drug dispensed by prescription if a prescription drug poses a substantial risk to the person consuming the drug when taken in combination with alcohol or if the drug may impair a persons ability to drive a motor vehicle, and the board has determined that the drug is a drug or drug type for which this warning shall be given. A violation of the Pharmacy Law is a crime.This bill would require a pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products to display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information. The bill would require a pharmacy to develop a cannabis labeling guideline on which medications require a label pursuant to the bill. Because a violation of this requirement would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YES
Amended IN Assembly March 23, 2023
Amended IN Assembly March 23, 2023
CALIFORNIA LEGISLATURE 20232024 REGULAR SESSION
Assembly Bill
No. 1619
Introduced by Assembly Member DixonFebruary 17, 2023
Introduced by Assembly Member Dixon
February 17, 2023
An act to add Section 4074.1 to the Business and Professions Code, relating to pharmacy.
LEGISLATIVE COUNSEL'S DIGEST
## LEGISLATIVE COUNSEL'S DIGEST
AB 1619, as amended, Dixon. Pharmacists: drug disclosures: cannabis or cannabidiol interactions.
The Pharmacy Law provides for the licensure and regulation of pharmacists by the California State Board of Pharmacy. Existing law requires a pharmacist to inform a patient orally or in writing of the harmful effects of a drug dispensed by prescription if a prescription drug poses a substantial risk to the person consuming the drug when taken in combination with alcohol or if the drug may impair a persons ability to drive a motor vehicle, and the board has determined that the drug is a drug or drug type for which this warning shall be given. A violation of the Pharmacy Law is a crime.This bill would require a pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products to display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information. The bill would require a pharmacy to develop a cannabis labeling guideline on which medications require a label pursuant to the bill. Because a violation of this requirement would be a crime, the bill would impose a state-mandated local program.The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that no reimbursement is required by this act for a specified reason.
The Pharmacy Law provides for the licensure and regulation of pharmacists by the California State Board of Pharmacy. Existing law requires a pharmacist to inform a patient orally or in writing of the harmful effects of a drug dispensed by prescription if a prescription drug poses a substantial risk to the person consuming the drug when taken in combination with alcohol or if the drug may impair a persons ability to drive a motor vehicle, and the board has determined that the drug is a drug or drug type for which this warning shall be given. A violation of the Pharmacy Law is a crime.
This bill would require a pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products to display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information. The bill would require a pharmacy to develop a cannabis labeling guideline on which medications require a label pursuant to the bill. Because a violation of this requirement would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
## Digest Key
## Bill Text
The people of the State of California do enact as follows:SECTION 1. Section 4074.1 is added to the Business and Professions Code, to read:4074.1. (a) A pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products shall display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information.(b) A pharmacy shall develop a cannabis labeling guideline on which medications require a label pursuant to subdivision (a).SEC. 2. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
The people of the State of California do enact as follows:
## The people of the State of California do enact as follows:
SECTION 1. Section 4074.1 is added to the Business and Professions Code, to read:4074.1. (a) A pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products shall display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information.(b) A pharmacy shall develop a cannabis labeling guideline on which medications require a label pursuant to subdivision (a).
SECTION 1. Section 4074.1 is added to the Business and Professions Code, to read:
### SECTION 1.
4074.1. (a) A pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products shall display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information.(b) A pharmacy shall develop a cannabis labeling guideline on which medications require a label pursuant to subdivision (a).
4074.1. (a) A pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products shall display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information.(b) A pharmacy shall develop a cannabis labeling guideline on which medications require a label pursuant to subdivision (a).
4074.1. (a) A pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products shall display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information.(b) A pharmacy shall develop a cannabis labeling guideline on which medications require a label pursuant to subdivision (a).
4074.1. (a) A pharmacy or healing arts licensee pharmacist that dispenses a prescription drug to a patient for outpatient use that has major or moderate interactions with edible or inhaled cannabis or cannabidiol products shall display on the label or container adequate warning of those interactions. affix an auxiliary label to the prescription container with that information.
(b) A pharmacy shall develop a cannabis labeling guideline on which medications require a label pursuant to subdivision (a).
SEC. 2. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SEC. 2. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SEC. 2. No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
### SEC. 2.